Floatz logo

Yttrium-90

Colorectal Carcinoma Metastatic in the Liver

Brown UniversityradiopharmaceuticalPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Colorectal Carcinoma Metastatic in the Liver cohort.

Asset / SponsorPhaseRating
Atezolizumab
Brown University
Phase 2B
Temsirolimus
M.D. Anderson Cancer Center
Phase 1CCC
Iodine I 124 Monoclonal Antibody M5A
City of Hope Medical Center
Phase 1CC
Inno-206
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

Yttrium-90 is also rated in:

hepatocellular carcinomaDormant
B
Indicative ·
58 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
58 / 100
View asset →
Liver Cancer (Locally Advanced or Metastatic)Dormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →